GHP-88310
Appearance
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C16H14N4O |
| Molar mass | 278.315 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
GHP-88310 (EIDD-3608) is an antiviral drug developed to target the measles morbillivirus, and also shows action against several related orthoparamyxoviruses. Prevalence of measles infection has grown in recent years due to declining vaccination rates, so development of effective antiviral drugs has become increasingly important. GHP-88310 is a broad-spectrum inhibitor of viral polymerases which are required for virus replication, and as well as measles itself, also shows efficacy against human parainfluenza virus type 3, Sendai virus and canine distemper virus in animal models.[1][2]
See also
[edit]References
[edit]- ↑ Lieber CM, Wolf JD, Govindarajan M, Yoon JJ, Sticher ZM, Ruckel CE, et al. (May 2026). "Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models". Science Advances. 12 (21) eaef1594. doi:10.1126/sciadv.aef1594. PMC 13196758. PMID 42172325.
- ↑ Lieber CM, Wolf JD, Ruckel CE, Harrison LA, Plemper RK (July 2026). "Antiviral GHP-88310 blocks contact-mediated and airborne transmission in a ferret model of measles-like disease". Nature Microbiology. doi:10.1038/s41564-026-02419-y. PMID 42498819.